Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

A Phase 2 Study of Olverembatinib for the Treatment of Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement

Suning Chen, Depei Wu, Wenzhi CAI, Xueqing Dou, Zhenfang Liu, Yu Zhu, Ying Wang, Chunmei Yang, Jiong Hu, Miao Miao, Xiuzhi Deng, Chunyan Chen

Blood (2024) 144 (Supplement 1): 1781.

https://doi.org/10.1182/blood-2024-200003

Published: 2024

Journal Articles

Tigit: The Potential Mechanisms of Relapse in Multiple Myeloma Following Anti-BCMA CAR-T Therapy and a Promising Target for Improving CAR-T Efficacy

Yuan Xia, Xuxing Shen, Min Shi, Na Shen, Yu Zhu, Lei Fan, Jianyong Li, Lijuan Chen

Blood (2024) 144 (Supplement 1): 2033.

https://doi.org/10.1182/blood-2024-205126

Published: 2024

Journal Articles

Olverembatinib 30 Mg Versus 40 Mg Every Other Day (QOD) in Patients with Tyrosine Kinase Inhibitor (TKI) Resistant or Intolerant Chronic-Phase Chronic Myeloid Leukemia (CML-CP): A Multi-Center Propensity Score-Matched Analysis

Blood (2024) 144 (Supplement 1): 4529.

https://doi.org/10.1182/blood-2024-203533

Published: 2024

Journal Articles

Predictive Models for Discontinuation of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia

Fang Cheng, Yu Wang, Xin Du, Yu Zhu, Jianyu Weng, Na Xu, Yunfan Yang, Jian Huang, Zhenfang Liu, Hongbo Ren, Huifang Zhao, Yajuan Ke, Weiyan Wu, Huanling Zhu, Qian Jiang, Yanli Zhang, Weiming Li

Blood (2024) 144 (Supplement 1): 4540.

https://doi.org/10.1182/blood-2024-202876

Published: 2024

Journal Articles

Relationship between Sarcopenia and the Heterogeneity and Microenvironment of Acute Myeloid Leukemia Based on Single-Cell Transcriptome Sequencing

Qian Sun, Wenjie Liu, Ming Hong, Yu Zhu, Jianyong Li, Sixuan Qian

Blood (2023) 142 (Supplement 1): 6026.

https://doi.org/10.1182/blood-2023-173220

Published: 2023

Journal Articles

Update Results of a Phase II Trial of Venetoclax in Combination with Azacitidine and Chidamide in Relapsed/Refractory Acute Myeloid Leukemia

Blood (2023) 142 (Supplement 1): 4274.

https://doi.org/10.1182/blood-2023-182832

Published: 2023

Journal Articles

Flumatinib Versus Nilotinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia

Blood (2023) 142 (Supplement 1): 1797.

https://doi.org/10.1182/blood-2023-179073

Published: 2023

Journal Articles

Preclinical Studies and Phase II Trial of Venetoclax in Combination with Chidamide and Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia

Blood (2022) 140 (Supplement 1): 3292–3293.

https://doi.org/10.1182/blood-2022-165261

Published: 2022

Journal Articles

The Prognosis of Intermediate- and High-Risk Young AML Patients Who Did Not Receive Allo-HSCT Treated with Intensive Chemotherapy Is Not Superior to That of Elderly AML Patients Treated with the D-CAG Regimen

Ming Hong, Qian Sun, Wenjie Liu, Han Zhu, Yu Zhu, Jianyong Li, Sixuan Qian

Blood (2021) 138 (Supplement 1): 1228.

https://doi.org/10.1182/blood-2021-149060

Published: 2021

Journal Articles

The Decrease of Anti-CD3 Antibody Concentration Improved the Cytotoxicity of Chimeric Antigen Receptor (CAR) T Cells in the Treatment of Chronic Lymphoblastic Leukemia (CLL)

Sanmei Wang, Yilian Yang, Yu Zhu, Lei Fan, Michael Schmitt, Maria Luisa Schubert, Jianyong Li

Blood (2021) 138 (Supplement 1): 4792.

https://doi.org/10.1182/blood-2021-150661

Published: 2021

Journal Articles

Retrospective Analysis of Chinese Chronic Myeloid Leukemia Patients Who Have Stopped Tyrosine Kinase Inhibitors

Xiaojian Zhu, Yong You, PhD, Yicheng Zhang, MD PhD, Minghui Duan, MD, Yu Zhu, MD PhD, Bingcheng Liu, MD, Xin Du, MD, Suning Chen, PhD

Blood (2018) 132 (Supplement 1): 5443.

https://doi.org/10.1182/blood-2018-99-113854

Published: 2018

Journal Articles

Reactivation of Hepatitis B Virus Infection in Aplastic Anemia Patients Receiving Immunosuppressive Therapy

Hua Yin, Suli Wang, Xingyu Lu, Wenyi Shen, MD, Ruinan Lu, Yu Zhu, MD PhD, Kourong Miao, Ming Hong, MD PhD, Shuai Wang, MD PhD, Jianfu Zhang, Chun Qiao, Yujie Wu, Xuemei Wu, Guangsheng He, Jianyong Li, MD PhD

Blood (2018) 132 (Supplement 1): 5107.

https://doi.org/10.1182/blood-2018-99-118836

Published: 2018

Journal Articles

PFKFB3 Is a Crucial Target in the Treatment of Tyrosine Kinase Inhibitor Resistant Chronic Myelogenous Leukemia

Yu Zhu, Jianyong Li, Chun Qiao, Yi Shan, MD, Sixuan Qian, Yaoyu Chen, Ming Hong, Huihui Zhao, Huapeng LI, Xuejun Zhu, Yang Zhongfa

Blood (2016) 128 (22): 3936.

https://doi.org/10.1182/blood.V128.22.3936.3936

Published: 2016

Journal Articles

TP53-Induced Glycolysis and Apoptosis Regulator Protects from Spontaneous Apoptosis and Predicts Poor Prognosis in Chronic Lymphocytic Leukemia

Ming Hong, Yi Xia, Yu Zhu, MD, Huihui Zhao, Yue Xie, Lei Fan, MD, PhD, Li Wang, Kourong Miao, MD, Wei Wu, Huayuan Zhu, MD, Yaoyu Chen, Wei Xu, Sixuan Qian, Jianyong Li

Blood (2016) 128 (22): 5101.

https://doi.org/10.1182/blood.V128.22.5101.5101

Published: 2016

Journal Articles

Adult Patients with Acquired Pure Red Cell Aplasia: Treated By Cyclosporine a and/or Corticosteroids--Single Center Experience

Xuemei Wu, MS., Suli Wang, MS., Wenyi Shen, MD, Yu Zhu, MD, Rui-Nan Lu, MD, PhD, Guangsheng He, MD, Jianyong Li, MD PhD

Blood (2016) 128 (22): 4818.

https://doi.org/10.1182/blood.V128.22.4818.4818

Published: 2016

Journal Articles

GABP Transcription Factor Is Required for B Lymphocyte Maturation and Plasma Cell Development

Zhongfa Yang, PhD, Yu Zhu, MD PhD, Rachel Gerstein, PhD, Alan G. Rosmarin, MD

Blood (2015) 126 (23): 1179.

https://doi.org/10.1182/blood.V126.23.1179.1179

Published: 2015

Journal Articles

Priming Regiments Based on Idarubicin, or Aclacinomycin or Pirarubicin Combining with Cytarabine and Granulocyte-Colony Stimulating Factor for Reinduction of Refractory/Relapsed Acute Lymphoblastic Leukemia

Yu Zhu, MD, Guangsheng He, MD, Kourong Miao, MD, Huayuan Zhu, MD, Weyi Shen, MD, Wang Shuai

Blood (2015) 126 (23): 4550.

https://doi.org/10.1182/blood.V126.23.4550.4550

Published: 2015

Journal Articles

Risk-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma: analysis from a multicenter study

Yong Yang, Yuan Zhu, Jian-Zhong Cao, Yu-Jing Zhang, Li-Ming Xu, Zhi-Yong Yuan, Jun-Xin Wu, Wei Wang, Tao Wu, Bing Lu, Su-Yu Zhu, Li-Ting Qian, Fu-Quan Zhang, Xiao-Rong Hou, Ye-Xiong Li

Blood (2015) 126 (12): 1424–1432.

https://doi.org/10.1182/blood-2015-04-639336

Published: 2015

Includes: Supplemental data

Journal Articles

Decitabine, low-dose cytarabine and aclarubicin combination with granulocyte colony-stimulating factor priming for the induction chemotherapy of older patients with myelodysplastic syndromes and acute myeloid leukemia

Sixuan Qian, Run Zhang, M.D., Yu Zhu, Hua Lu, Peng Liu, Hongxia Qiu, Hanxin Wu, Ming Hong, Jianyong Li

Blood (2012) 120 (21): 1520.

https://doi.org/10.1182/blood.V120.21.1520.1520

Published: 2012

Journal Articles

Cotransplantation of HLA-Identical Mesenchymal Stem Cells and Hematopoietic Stem Cells in Chinese Patients with Hematologic Diseases.

Xiaoyan Zhang, Jianyong Li, Kejiang Cao, Hanxin Wu, Hua Lu, Peng Liu, Sixuan Qian, Wei Xu, Wenyi Shen, Yu Zhu

Blood (2007) 110 (11): 5061.

https://doi.org/10.1182/blood.V110.11.5061.5061

Published: 2007

NARROW

A Phase 2 Study of Olverembatinib for the Treatment of Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement

Tigit: The Potential Mechanisms of Relapse in Multiple Myeloma Following Anti-BCMA CAR-T Therapy and a Promising Target for Improving CAR-T Efficacy

Olverembatinib 30 Mg Versus 40 Mg Every Other Day (QOD) in Patients with Tyrosine Kinase Inhibitor (TKI) Resistant or Intolerant Chronic-Phase Chronic Myeloid Leukemia (CML-CP): A Multi-Center Propensity Score-Matched Analysis

Predictive Models for Discontinuation of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia

Relationship between Sarcopenia and the Heterogeneity and Microenvironment of Acute Myeloid Leukemia Based on Single-Cell Transcriptome Sequencing

Update Results of a Phase II Trial of Venetoclax in Combination with Azacitidine and Chidamide in Relapsed/Refractory Acute Myeloid Leukemia

Flumatinib Versus Nilotinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia

Preclinical Studies and Phase II Trial of Venetoclax in Combination with Chidamide and Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia

The Prognosis of Intermediate- and High-Risk Young AML Patients Who Did Not Receive Allo-HSCT Treated with Intensive Chemotherapy Is Not Superior to That of Elderly AML Patients Treated with the D-CAG Regimen

The Decrease of Anti-CD3 Antibody Concentration Improved the Cytotoxicity of Chimeric Antigen Receptor (CAR) T Cells in the Treatment of Chronic Lymphoblastic Leukemia (CLL)

Retrospective Analysis of Chinese Chronic Myeloid Leukemia Patients Who Have Stopped Tyrosine Kinase Inhibitors

Reactivation of Hepatitis B Virus Infection in Aplastic Anemia Patients Receiving Immunosuppressive Therapy

PFKFB3 Is a Crucial Target in the Treatment of Tyrosine Kinase Inhibitor Resistant Chronic Myelogenous Leukemia

TP53-Induced Glycolysis and Apoptosis Regulator Protects from Spontaneous Apoptosis and Predicts Poor Prognosis in Chronic Lymphocytic Leukemia

Adult Patients with Acquired Pure Red Cell Aplasia: Treated By Cyclosporine a and/or Corticosteroids--Single Center Experience

GABP Transcription Factor Is Required for B Lymphocyte Maturation and Plasma Cell Development

Priming Regiments Based on Idarubicin, or Aclacinomycin or Pirarubicin Combining with Cytarabine and Granulocyte-Colony Stimulating Factor for Reinduction of Refractory/Relapsed Acute Lymphoblastic Leukemia

Risk-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma: analysis from a multicenter study

Decitabine, low-dose cytarabine and aclarubicin combination with granulocyte colony-stimulating factor priming for the induction chemotherapy of older patients with myelodysplastic syndromes and acute myeloid leukemia

Cotransplantation of HLA-Identical Mesenchymal Stem Cells and Hematopoietic Stem Cells in Chinese Patients with Hematologic Diseases.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only